Bank Of Montreal Bluebird Bio, Inc. Transaction History

Bank Of Montreal

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$2.94 - $5.23 $251,002 - $446,511	85,375 Added 725.98%	97,135 $405,000
Q1 2022 May 12, 2022	BUY	$4.07 - $10.6 $47,863 - $124,656	11,760 New	11,760 $58,000
Q4 2021 Feb 11, 2022	SELL	$8.96 - $16.31 $150,895 - $274,676	-16,841 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$11.24 - $21.0 $19,074 - $35,637	-1,697 Reduced 9.15%	16,841 $330,000
Q2 2021 Aug 12, 2021	BUY	$18.04 - $22.09 $334,425 - $409,504	18,538 New	18,538 $574,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.